Journal List > Korean J Gastroenterol > v.58(2) > 1006904

TOOLS
Shin: Could Antibiotic Resistance Rate of Helicobacter pylori be Different according to Gastroduodenal Diseases?
Editorial

Korean J Gastroenterol 2011;58(2):65-66.

Published online: 4 October 2011

DOI: https://doi.org/10.4166/kjg.2011.58.2.65

Could Antibiotic Resistance Rate of Helicobacter pylori be Different according to Gastroduodenal Diseases?

Woon Geon Shin

Department of Internal Medicine, Hallym University College of Medicine, Seoul, Korea

Correspondence to: Woon Geon Shin, Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, 445, Gil-dong, Kangdong-gu, Seoul 134-701, Korea. Tel: +82-2-2225-2814, Fax: +82-2-478-6925, E-mail: sgun91@hallym.or.kr

Copyright © 2011 Korean Ophthalmological Society

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Article

Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea

References

1. Korean Helicobacter pylori Study Group. Diagnosis and treatment for Helicobacter pylori infection in Korea. Korean J Gastroenterol. 1998; 32:275–289.
2. Lee YC, Lee SY, Pyo JH, Kwon DH, Rhee JC, Kim JJ. Isogenic variation of Helicobacter pylori strain resulting in heteroresistant an-tibacterial phenotypes in a single host in vivo. Helicobacter. 2005; 10:240–248.
3. National Committee for Clinical Laboratory Standards. Acceptable limits for quality control strains used to monitor accuracy of minimal inhibitory concentrations of fastidious organisms. Performance standards for antimicrobial susceptibility testing, 12th informational supplement M100-S12. 22:no. 1.Wayne (PA): NCCLS;2002. p. 117–121.
4. Kim JG. Treatment of Helicobacter pylori infection. Korean J Gastroenterol. 2005; 46:172–180.
5. Gisbert JP, Marcos S, Gisbert JL, Pajares JM. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia. Eur J Gastroenterol Hepatol. 2001; 13:1303–1307.
6. Chung SJ, Lee DH, Kim N, et al. Eradication rates of Helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease. Hepatogastroenterology. 2007; 54:1293–1296.
7. Kim JY, Kim N, Kim JM, et al. Primary antibiotic resistance of Helicobacter pylori strains and eradication rate depending on gastroduodenal disease. Korean J Gastroenterol. 2011; 58:74–81.
8. Kim JM. Antibiotic resistance of Helicobacter pylori isolated from Korean patients. Korean J Gastroenterol. 2006; 47:337–349.
TOOLS
Similar articles